retatrutide pep ποΈ NEW EPISODE: RetatrutideβThe Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide 20mg - Coastal Peps
Description
GLP-1R activation by retatrutide promotes glucose-dependent insulin secretion, suppresses glucagon during hyperglycemia, delays gastric emptying, and reduces appetite via CNS signaling

Our overview of tirzepatide sourcing options and the broader research vs pharmaceutical peptide comparison can inform that conversation

Washio et al., 2016)

And a GLP-1 named Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration this spring

AUTHOR CONTRIBUTIONS Conception or design: all authors
